Literature DB >> 16911910

Association of functional and health status measures in heart failure.

Jonathan Myers1, Nayma Zaheer, Susan Quaglietti, Rupa Madhavan, Victor Froelicher, Paul Heidenreich.   

Abstract

BACKGROUND: A wide variety of instruments have been used to assess the functional capabilities and health status of patients with chronic heart failure (HF), but it is not known how well these tests are correlated with one another, nor which one has the best association with measured exercise capacity. METHODS AND
RESULTS: Forty-one patients with HF were assessed with commonly used functional, health status, and quality of life measures, including maximal cardiopulmonary exercise testing, the Duke Activity Status Index (DASI), the Veterans Specific Activity Questionnaire (VSAQ), the Kansas City Cardiomyopathy Questionnaire (KCCQ), and 6-minute walk distance. Pretest clinical variables, including age, resting pulmonary function tests (forced expiratory volume in 1 s and forced vital capacity), and ejection fraction (EF) were also considered. The association between performance on these functional tools, clinical variables, and exercise test responses including peak VO2 and the VO2 at the ventilatory threshold, was determined. Peak oxygen uptake (VO2) was significantly related to VO2 at the ventilatory threshold (r = 0.76, P < .001) and estimated METs from treadmill speed and grade (r = 0.72, P < .001), but had only a modest association with 6-minute walk performance (r = 0.49, P < .01). The functional questionnaires had modest associations with peak VO2 (r = 0.37, P < .05 and r = 0.26, NS for the VSAQ and DASI, respectively). Of the components of the KCCQ, peak VO2 was significantly related only to quality of life score (r = 0.46, P < .05). Six-minute walk performance was significantly related to KCCQ physical limitation (r = 0.53, P < .01) and clinical summary (r = 0.44, P < .05) scores. Among pretest variables, only age and EF were significantly related to peak VO2 (r = -0.58, and 0.46, respectively, P < .01). Multivariately, age and KCCQ quality of life score were the only significant predictors of peak VO2, accounting for 72% of the variance in peak VO2.
CONCLUSION: Commonly used functional measures, symptom tools, and quality of life assessments for patients with HF are poorly correlated with one another and are only modestly associated with exercise test responses. These findings suggest that exercise test responses, non-exercise test estimates of physical function, and quality of life indices reflect different facets of health status in HF and one should not be considered a surrogate for another.

Entities:  

Mesh:

Year:  2006        PMID: 16911910     DOI: 10.1016/j.cardfail.2006.04.004

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  34 in total

1.  Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study.

Authors:  Razi Khan; David Massel; John Stirrat; David Scholl; Gerald Wisenberg; Terry Thompson; Maria Drangova; James A White
Journal:  Int J Cardiovasc Imaging       Date:  2012-08-09       Impact factor: 2.357

2.  Does Angiotensin Receptor Neprilysin Inhibitor (ARNI) Improve Functional Capacity Assessed by 6 Minutes Walking Test?

Authors:  Merce Faraudo; Paola Beltran; Roman Freixa; Elisabet Mena; Olga Guri; Anna Contra; Luís Miguel Ceresuela; Josep Masip
Journal:  Eur Cardiol       Date:  2017-12

3.  Symptom-Hemodynamic Mismatch and Heart Failure Event Risk.

Authors:  Christopher S Lee; Shirin O Hiatt; Quin E Denfeld; James O Mudd; Christopher Chien; Jill M Gelow
Journal:  J Cardiovasc Nurs       Date:  2015 Sep-Oct       Impact factor: 2.083

4.  Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living With Heart Failure Questionnaire in Predicting Heart Failure Outcomes.

Authors:  Derek Yee; Eric Novak; Anne Platts; Michael E Nassif; Shane J LaRue; Justin M Vader
Journal:  Am J Cardiol       Date:  2018-12-04       Impact factor: 2.778

5.  Comparative symptom biochemistry between moderate and advanced heart failure.

Authors:  Christopher S Lee; Quin E Denfeld; Bradley E Aouizerat; Corrine Y Jurgens; Christopher V Chien; Emily Aarons; Jill M Gelow; Shirin O Hiatt; James O Mudd
Journal:  Heart Lung       Date:  2018-10-09       Impact factor: 2.210

Review 6.  Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Daniel E Forman; Ross Arena; Rebecca Boxer; Mary A Dolansky; Janice J Eng; Jerome L Fleg; Mark Haykowsky; Arshad Jahangir; Leonard A Kaminsky; Dalane W Kitzman; Eldrin F Lewis; Jonathan Myers; Gordon R Reeves; Win-Kuang Shen
Journal:  Circulation       Date:  2017-03-23       Impact factor: 29.690

7.  N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.

Authors:  G Michael Felker; David Whellan; William E Kraus; Robert Clare; Faiez Zannad; Mark Donahue; Kirkwood Adams; Robert McKelvie; Ileana L Piña; Christopher M O'Connor
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

8.  Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure.

Authors:  Kathryn E Flynn; Li Lin; Stephen J Ellis; Stuart D Russell; John A Spertus; David J Whellan; Ileana L Piña; Lawrence J Fine; Kevin A Schulman; Kevin P Weinfurt
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

9.  Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failure.

Authors:  Justin L Grodin; Muhammad Hammadah; Yiying Fan; Stanley L Hazen; W H Wilson Tang
Journal:  J Card Fail       Date:  2014-08-28       Impact factor: 5.712

10.  Sleep and health-related quality of life in heart failure.

Authors:  Paul J Mills; Joel E Dimsdale; Loki Natarajan; Michael G Ziegler; Alan Maisel; Barry H Greenberg
Journal:  Congest Heart Fail       Date:  2009 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.